1996
DOI: 10.1002/(sici)1097-0215(19960729)67:3<333::aid-ijc5>3.3.co;2-r
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
44
1
2

Year Published

1999
1999
2013
2013

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 36 publications
(49 citation statements)
references
References 0 publications
2
44
1
2
Order By: Relevance
“…Of note was the absence of a significant increase in plasma levels of active TGF-␤. This was a surprise because we had previously reported that HNSCC secrete TGF-␤ [16,20]. Also, others had demonstrated increased levels of TGF-␤ in patients with other malignancies, such as colorectal or prostate cancer [21][22][23].…”
Section: Discussionmentioning
confidence: 99%
“…Of note was the absence of a significant increase in plasma levels of active TGF-␤. This was a surprise because we had previously reported that HNSCC secrete TGF-␤ [16,20]. Also, others had demonstrated increased levels of TGF-␤ in patients with other malignancies, such as colorectal or prostate cancer [21][22][23].…”
Section: Discussionmentioning
confidence: 99%
“…Phenotypically, TIL look like activated T cells, but these cells are functionally compromised [12]. In situ immunostaining with antibodies specific for T cell receptor (TcR)-associated signaling molecules as well as functional assays with TIL isolated from the tumor bed identified the following defects in these cells: absent or low expression of the ζ chain, which is the key signaling molecule in the TcR pathway [12,13]; decreased proliferation in response to mitogens or IL-2 [11,12]; inability to kill tumor cell targets [11]; imbalance in the cytokine profile, with the striking absence of IL-2 or IFN-γ production [14]; and evidence for DNA fragmentation in a considerable proportion of infiltrating T cells [12]. More recent studies confirm and extend these findings, as summarized in Table 2.…”
Section: Strategies Of Tumor Escapementioning
confidence: 99%
“…Not only do HNSCC tumors evade the immune system, they actively suppress anti-tumor immune responses through production of immune suppressive soluble factors and induction of immune inhibitory cells. The production of immune suppressive soluble factors, including TGF-b [53,54], prostaglandins [55], and FasL [56], actively suppresses anti-tumor effector mechanisms. The presence of immune inhibitory cells, including CD34 + progenitor cells, inhibitory macrophages, and T-regulatory cells, within the tumor and peripheral blood of HNSCC patients contribute to continued tumor survival and metastases by actively inhibiting T-cell anti-tumor effector mechanisms [4,57].…”
Section: Immunological Contributions To Mechanisms Of Tumor Growth Anmentioning
confidence: 99%